171 related articles for article (PubMed ID: 17334718)
1. Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy.
Murakami D; Tsujitani S; Osaki T; Saito H; Katano K; Tatebe S; Ikeguchi M
Gastric Cancer; 2007; 10(1):45-51. PubMed ID: 17334718
[TBL] [Abstract][Full Text] [Related]
2. Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.
Tsujitani S; Saito H; Wakatsuki T; Ikeguchi M; Shirabe K; Morita M; Kakeji Y; Yano T; Maehara Y
Surg Today; 2012 Feb; 42(3):225-32. PubMed ID: 22143356
[TBL] [Abstract][Full Text] [Related]
3. Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis.
Nam SY; Lee HS; Jung GA; Choi J; Cho SJ; Kim MK; Kim WH; Lee BL
APMIS; 2003 Dec; 111(12):1105-13. PubMed ID: 14678019
[TBL] [Abstract][Full Text] [Related]
4. Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma.
Maeta Y; Tsujitani S; Matsumoto S; Yamaguchi K; Tatebe S; Kondo A; Ikeguchi M; Kaibara N
Gastric Cancer; 2004; 7(2):78-84. PubMed ID: 15224193
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for recurrence in stage II and III gastric cancer patients receiving a curative resection and postoperative adjuvant chemotherapy.
Tsujinaka T; Shiozaki H; Yano M; Kikkawa N; Takami M; Monden M
Oncol Rep; 2001; 8(1):33-8. PubMed ID: 11115565
[TBL] [Abstract][Full Text] [Related]
6. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
7. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
Tsujitani S; Konishi I; Suzuki K; Oka S; Gomyo Y; Matsumoto S; Hirooka Y; Kaibara N
J Exp Clin Cancer Res; 2000 Jun; 19(2):189-95. PubMed ID: 10965817
[TBL] [Abstract][Full Text] [Related]
8. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy.
Yeh KH; Shun CT; Chen CL; Lin JT; Lee WJ; Lee PH; Chen YC; Cheng AL
Hepatogastroenterology; 1999; 46(25):610-5. PubMed ID: 10228869
[TBL] [Abstract][Full Text] [Related]
10. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B phosphorylation correlates with vascular endothelial growth factor A and microvessel density in gastric adenocarcinoma.
Zhou XD; Chen HX; Guan RN; Lei YP; Shu X; Zhu Y; Lv NH
J Int Med Res; 2012; 40(6):2124-34. PubMed ID: 23321169
[TBL] [Abstract][Full Text] [Related]
12. Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer.
Cao Y; Liu H; Li H; Lin C; Li R; Wu S; Zhang H; He H; Zhang W; Xu J
JAMA Surg; 2017 Nov; 152(11):e173120. PubMed ID: 28903131
[TBL] [Abstract][Full Text] [Related]
13. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
Wada T; Kunisaki C; Hasegawa S; Takagawa R; Momiyama M; Kosaka T; Makino H; Ono HA; Oshima T; Akiyama H; Endo I
Anticancer Res; 2013 Apr; 33(4):1747-51. PubMed ID: 23564827
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients.
Mitsuno M; Kitajima Y; Ide T; Ohtaka K; Tanaka M; Satoh S; Miyazaki K
J Gastroenterol; 2007 Nov; 42(11):866-73. PubMed ID: 18008030
[TBL] [Abstract][Full Text] [Related]
17. Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Terashima M; Fujiwara H; Takagane A; Abe K; Irinoda T; Nakaya T; Yonezawa H; Oyama K; Saito K; Kanzaki N; Ohtani S; Nemoto T; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2003; 6 Suppl 1():71-81. PubMed ID: 12775024
[TBL] [Abstract][Full Text] [Related]
18. P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection.
Liang JT; Huang KC; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Chang KJ
Int J Cancer; 2002 Feb; 97(4):451-7. PubMed ID: 11802206
[TBL] [Abstract][Full Text] [Related]
19. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin.
Nagashima F; Boku N; Ohtsu A; Yoshida S; Hasebe T; Ochiai A; Sakata Y; Saito H; Miyata Y; Hyodo I; Ando M
Jpn J Clin Oncol; 2005 Dec; 35(12):714-9. PubMed ID: 16303791
[TBL] [Abstract][Full Text] [Related]
20. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
